Quanterix (QTRX)
(Real Time Quote from BATS)
$13.33 USD
-0.09 (-0.67%)
Updated Aug 6, 2024 09:54 AM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QTRX 13.33 -0.09(-0.67%)
Will QTRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QTRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QTRX
BellRing Brands (BRBR) Q3 Earnings and Revenues Top Estimates
Ayr Wellness Inc. (AYRWF) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
QTRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for
Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
Other News for QTRX
Quanterix To Report Second Quarter 2024 Financial Results
What's Driving Avanos Medical Inc's Surprising 34% Stock Rally?
Buy Recommendation for Quanterix Amid Strong Prospects in Alzheimer’s Diagnostics
Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer?s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
Quanterix presents new Alzheimer's disease data at AAIC